Investment analysts at Leerink Partnrs issued their Q1 2025 earnings estimates for Merus in a research report issued to clients and investors on Wednesday, February 5th. Leerink Partnrs analyst A.

Cystic-fibrosis-focused Sionna Therapeutics made its public debut this week, with an upsized public offering. Meanwhile, Titan America had a ...

Cytokinetics (CYTK) was initiated by Citi analysts with a Buy rating, citing potential FDA approval for its lead asset aficamten. Read more here.

After more than a decade of planning, a 4.5-mile portion of U.S. Highway 212’s four-lane expansion has begun.Stretching from Cologne (Highway 36) to Carver (Highway 11/Jonathan Carver ...

Palantir Technologies shares are trading at all-time highs on Thursday on what appears to be continued momentum in the wake of the company's strong fourth-quarter financial results. Here's what you ...

Leonteq AG (SIX: LEON) today announced the appointment of Christian Spieler as Leonteq’s CEO effective 1 March 2025.

The Bank of England looks set to cut interest rates on Thursday for only the third time since just after the start of the ...

As rival banks like JPMorgan and Goldman Sachs mandate five days in the office, Citi sees its hybrid schedule as a key ...

The commercial banking operation is Citi's most unique business, as its global footprint is hard to replicate. This international presence will help Citigroup remain a bank of choice for cross-border ...

Q4 2024 Management View CEO Albert Bourla highlighted Pfizer's strong execution in 2024, emphasizing the successful integration of Seagen, which has positioned Pfizer as a leading oncology company. He ...

Q4 2024 Earnings Conference Call February 4, 2025 10:30 AM ETCompany ParticipantsFrancesca DeMartino - Senior Vice President, ...

In a week’s time, the $30 billion reverse merger between Sigma Healthcare (ASX:SIG) and the hitherto unlisted Chemist Warehouse becomes effective, more than a year after the union was conceived ...